Epsilon Health Investors

Day-to-day investment decisions are led by co-founders Steven Epstein and Gregory Epstein. Both bring decades of healthcare sector experience from their roles at Epstein Becker & Green, P.C., where they built practices around regulatory, transactional, and governance issues for major health systems and providers.

Epsilon sources primarily through its strategic limited partner base. Its LPs include former CMS administrators, hospital CEOs, and the former chair of the American Hospital Association, as well as large health systems and payers. These relationships surface companies addressing acute operational pain points inside provider and payer organizations, often before those companies seek broad institutional funding rounds.

Epsilon operates as a venture capital firm managing third-party capital, not as a family office. Its LP base includes institutional healthcare organizations, family offices, and individual healthcare executives, creating a hybrid investor-syndicate structure that blurs the line between a traditional fund and a strategic corporate venture arm.

The firm makes direct venture investments, with the ability to lead rounds or participate as part of a syndicate. There is no public indication that it makes commitments to other venture funds as a limited partner.

Epsilon focuses on Seed+ through Series B rounds. This stage coverage is designed to capture companies that have moved past initial concept validation and are ready to begin scaling with enterprise healthcare customers — precisely the partners in Epsilon's LP base.

Epsilon was founded by Steven Epstein and Gregory Epstein, whose family name is on the large healthcare-focused law firm Epstein Becker & Green, P.C. While the firm draws on the network and regulatory expertise associated with that legacy, it operates as a separate investment management business.

Epsilon explicitly states that it can lead rounds or invest as part of a syndicate. This suggests a collaborative posture toward co-investing with other venture firms rather than an insistence on control position, consistent with its strategy of bringing strategic distribution partners alongside financial sponsors.